A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer
Completed · Phase 2
Conditions studied: Non-small Cell Lung Cancer
In brief
This is a Phase II, randomized, multi-center, multinational, open-label, cross-over study in adult participants with PD-L1-positive NSCLC. Two populations will be included: participants with resected Stage II, IIIA, and selected IIIB (T3-N2) NSCLC who have completed adjuvant platinum-based chemotherapy without evidence of disease relapse/recurrence, and chemotherapy-naïve participants with Stage IV NSCLC. The study will evaluate participant- and healthcare professionals (HCP)-reported preference for atezolizumab subcutaneous (SC) compared with atezolizumab intravenous (IV).
Key facts
- Study ID
- NCT05171777
- Run by
- Hoffmann-La Roche
- People needed
- 179
- Starts
- 2022-04-04
- Expected to finish
- 2024-10-25
- Last updated by the study team
- 2025-12-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New Jersey Hematology Oncology Associates LLC — Brick, New Jersey, United States
- Tri County Hematologyoncology — Massillon, Ohio, United States
- Asante Rogue Regional Medical Center — Medford, Oregon, United States
- UPMC - Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- Fundación CENIT para la Investigación en Neurociencias — Buenos Aires, Argentina
- CEMIC — Buenos Aires, Argentina
- Centro Oncologico Korben — Ciudad Autonoma Buenos Aires, Argentina
- Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda — Ijuí, Rio Grande do Sul, Brazil
- Hospital das Clinicas - UFRGS — Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Nossa Senhora da Conceicao — Porto Alegre, Rio Grande do Sul, Brazil
- Instituto do Cancer do Estado de Sao Paulo - ICESP — São Paulo, São Paulo, Brazil
- Royal Victoria Regional Health Centre — Barrie, Ontario, Canada
- Sault Area Hospital — Sault Ste. Marie, Ontario, Canada
- OrlandiOncología — Santiago, Chile
- Clinica CIMCA — San José, Costa Rica
- ICIMED Instituto de Investigación en Ciencias Médicas — San José, Costa Rica
- Oulun yliopistollinen sairaala (OYS) — Oulu, Finland
- Tampereen yliopistollinen sairaala (TAYS) — Tampere, Finland
- Turun yliopistollinen keskussairaala (TYKS) — Turku, Finland
- Vaasan Keskussairaala — Vaasa, Finland
- Azienda Ospedaliera Universitaria Senese — Siena, Abruzzo, Italy
- IRCCS Istituto Regina Elena (IFO) — Rome, Lazio, Italy
- Instituto Europeo di Oncologia — Milan, Lombardy, Italy
- A.O.U. Maggiore della Carità — Novara, Piedmont, Italy
- Pauls Stradins Clinical University Hospital — R?ga, Latvia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.